Quest Diagnostics Incorporated (DGX) stock analysis

In our weekly check, Quest Diagnostics Incorporated is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 21 pass, warnings: 2, red flags: 2.

About Quest Diagnostics Incorporated

Quest Diagnostics Incorporated is a Healthcare company (Diagnostics & Research) based in the United States, listed on NYSE as DGX.

What our checks show for DGX

Red flags

Warning signs

Strengths

Next earnings report: 2027-02-09

Similar companies

LH · ILMN · MTD · GH · IQV · MEDP

Questions

What grade does Quest Diagnostics Incorporated (DGX) have?

In our weekly check, Quest Diagnostics Incorporated is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 21 pass, warnings: 2, red flags: 2. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of DGX stock?

This week's biggest flags for Quest Diagnostics Incorporated: Margins falling, Gross margin falling, Weak revenue forecast. In total 4 of 25 checks show a warning or a red flag.

What does Quest Diagnostics Incorporated do?

Quest Diagnostics Incorporated is a Healthcare company (Diagnostics & Research) based in the United States, listed on NYSE as DGX.

When does Quest Diagnostics Incorporated report earnings next?

The next earnings report is expected on 2027-02-09. We re-run the checks every week, so the grade can change after it.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-11-14

Open the full analysis